Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

569.80 -19.50 (-3.31%)

New 52W Low today

772.9K NSE+BSE Volume

NSE 24 Nov, 2025 3:31 PM (IST)

21,798.7

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

30 Votes:

Buy 66.67%

Sell 16.67%

Hold 16.67%

RESEARCH REPORTS

Sell SEE REPORTS >

Buy SEE REPORTS >